glp-1 drugs chemically different clinically similar GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications GLP-1 Safety Check - National
Description
Theyre also expensive and not always covered by insurance
A study in The New England Journal of Medicine found that 59 percent of patients with NASH (non-alcoholic steatohepatitis) who took a high dose of semaglutide for 72 weeks saw improvement without worsening of fibrosis (or scarring)
If they do, that means dulaglutide, the active ingredient in Trulicity, could cause blood clots and DVT
were $173 billion
Cost Comparisons: GLP-1s vs
